Dr. Ray O’Connor reviews recent clinical studies on nephrology, focusing on chronic kidney disease (CKD). CKD is a major public health concern globally, with a high risk of cardiovascular diseases and death. Diabetes and hypertension are significant contributors to CKD, with diabetic kidney disease being a leading cause. Studies have shown promising results for new therapeutic interventions. Sarcopenia, a risk factor for adverse outcomes in CKD patients, is prevalent across all CKD stages, particularly in those on dialysis. Guidelines recommend individualized risk predictions for CKD patients, with new predictive models showing improved accuracy in predicting kidney failure and mortality outcomes.
Source link
You might be interested in…Nephrology
